Dr Reddy’s Laboratories problem with ensuring products reach the market at a quality the FDA deems acceptable is no secret and, unfortunately for the company, it has once again been slapped with a recall of over 80,000 bottles of Atorvastatin.
Only last month, it was forced to recall more than 1,000 Docetaxel injection vials used to treat breast cancer and was also hit by a fine for improperly packaging its products.
